Publications in collaboration with researchers from Hammersmith Hospital (1)

2016

  1. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

    British Journal of Cancer, Vol. 115, Núm. 7, pp. 789-796